Key points from article :
Vital Biosciences has raised $48 million to bring to market its revolutionary blood testing product, the VitalOne.
VitalOne conducts more than 50 lab-grade tests (95% of routine lab orders), with results available within just 20 minutes.
Using advancements in microfluidics, computer vision, biochemistry & robotics, the device will be running multiple lab tests in parallel.
Simple to use, with automated sample preparation and quality control features to minimize user time and risk of errors.
The goal is to enable doctors to conduct tests, diagnose and treat patients in a single visit.
New funding to further develop the product, conduct verification and validation activities, and to initiate clinical studies.
Enables a comprehensive suite of lab tests at primary care access points, such as clinics, pharmacies and in-home care.
Initial planned test for various patient populations, spanning general wellness, elder care, women’s health and urgent care.
It is still in late-stage development and not yet available for sale.
Recently showcased the VitalOne at the annual meeting of the American Association of Clinical Chemistry.
